VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $278,892,000 | +63.5% | 10,363,832 | +83.0% | 0.08% | +72.7% |
| Q2 2023 | $170,558,000 | +58.1% | 5,664,537 | +69.8% | 0.04% | +46.7% |
| Q1 2023 | $107,893,000 | -7.7% | 3,335,152 | -18.2% | 0.03% | -9.1% |
| Q4 2022 | $116,884,000 | +16.6% | 4,078,246 | -1.9% | 0.03% | +6.5% |
| Q3 2022 | $100,248,000 | -12.3% | 4,156,237 | -0.5% | 0.03% | -8.8% |
| Q2 2022 | $114,334,000 | -44.8% | 4,175,862 | -22.7% | 0.03% | -33.3% |
| Q1 2022 | $207,268,000 | +29.5% | 5,404,610 | +8.2% | 0.05% | +41.7% |
| Q4 2021 | $160,028,000 | -7.4% | 4,996,195 | -14.8% | 0.04% | -20.0% |
| Q3 2021 | $172,857,000 | -25.1% | 5,865,584 | -13.7% | 0.04% | -26.2% |
| Q2 2021 | $230,902,000 | +17.6% | 6,795,296 | +12.5% | 0.06% | +7.0% |
| Q1 2021 | $196,305,000 | -29.2% | 6,040,094 | -21.5% | 0.06% | -29.6% |
| Q4 2020 | $277,100,000 | -13.6% | 7,692,983 | -6.1% | 0.08% | -28.9% |
| Q3 2020 | $320,872,000 | +21.6% | 8,193,900 | +13.9% | 0.11% | +8.6% |
| Q2 2020 | $263,901,000 | +86.5% | 7,194,655 | +17.2% | 0.10% | +54.4% |
| Q1 2020 | $141,496,000 | -64.2% | 6,141,354 | -54.5% | 0.07% | -52.4% |
| Q4 2019 | $395,077,000 | +4.3% | 13,493,060 | -4.8% | 0.14% | -4.0% |
| Q3 2019 | $378,726,000 | +24.9% | 14,179,143 | +19.5% | 0.15% | +22.1% |
| Q2 2019 | $303,206,000 | +68.3% | 11,862,594 | +47.6% | 0.12% | +56.4% |
| Q1 2019 | $180,156,000 | -6.8% | 8,035,430 | -12.4% | 0.08% | -16.1% |
| Q4 2018 | $193,400,000 | +36.7% | 9,170,223 | +20.0% | 0.09% | +57.6% |
| Q3 2018 | $141,481,000 | -27.8% | 7,639,397 | -13.0% | 0.06% | -33.0% |
| Q2 2018 | $195,959,000 | -21.1% | 8,783,513 | -22.2% | 0.09% | -21.4% |
| Q1 2018 | $248,279,000 | -10.3% | 11,295,666 | -5.2% | 0.11% | -8.2% |
| Q4 2017 | $276,929,000 | -1.4% | 11,916,060 | -2.6% | 0.12% | -9.0% |
| Q3 2017 | $280,889,000 | -12.9% | 12,233,852 | -16.3% | 0.13% | -19.8% |
| Q2 2017 | $322,541,000 | +9.6% | 14,607,866 | +13.2% | 0.17% | +5.7% |
| Q1 2017 | $294,231,000 | +89.2% | 12,899,137 | +73.5% | 0.16% | +88.1% |
| Q4 2016 | $155,496,000 | +6.3% | 7,432,957 | +34.3% | 0.08% | +1.2% |
| Q3 2016 | $146,251,000 | +42.4% | 5,533,483 | +49.3% | 0.08% | +36.1% |
| Q2 2016 | $102,729,000 | – | 3,707,326 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |